Free Trial
NASDAQ:MGX

Metagenomi (MGX) Stock Price, News & Analysis

Metagenomi logo
$1.92 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.92 +0.01 (+0.26%)
As of 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Metagenomi Stock (NASDAQ:MGX)

Key Stats

Today's Range
$1.82
$1.97
50-Day Range
$1.42
$2.52
52-Week Range
$1.23
$4.92
Volume
361,689 shs
Average Volume
700,950 shs
Market Capitalization
$71.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00
Consensus Rating
Buy

Company Overview

Metagenomi Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

MGX MarketRank™: 

Metagenomi scored higher than 52% of companies evaluated by MarketBeat, and ranked 509th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Metagenomi has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Metagenomi has only been the subject of 2 research reports in the past 90 days.

  • Read more about Metagenomi's stock forecast and price target.
  • Earnings Growth

    Earnings for Metagenomi are expected to decrease in the coming year, from ($2.46) to ($2.52) per share.

  • Price to Book Value per Share Ratio

    Metagenomi has a P/B Ratio of 0.31. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Metagenomi's valuation and earnings.
  • Percentage of Shares Shorted

    6.10% of the float of Metagenomi has been sold short.
  • Short Interest Ratio / Days to Cover

    Metagenomi has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Metagenomi has recently decreased by 10.14%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Metagenomi does not currently pay a dividend.

  • Dividend Growth

    Metagenomi does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.10% of the float of Metagenomi has been sold short.
  • Short Interest Ratio / Days to Cover

    Metagenomi has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Metagenomi has recently decreased by 10.14%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Metagenomi this week, compared to 5 articles on an average week.
  • Search Interest

    5 people have searched for MGX on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Metagenomi to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Metagenomi insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $30,800.00 in company stock.

  • Percentage Held by Insiders

    17.80% of the stock of Metagenomi is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Metagenomi's insider trading history.
Receive MGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Metagenomi and its competitors with MarketBeat's FREE daily newsletter.

MGX Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
See More Headlines

MGX Stock Analysis - Frequently Asked Questions

Metagenomi's stock was trading at $3.61 on January 1st, 2025. Since then, MGX stock has decreased by 46.8% and is now trading at $1.92.

Metagenomi, Inc. (NASDAQ:MGX) posted its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.68) EPS for the quarter, missing analysts' consensus estimates of ($0.62) by $0.06. The business earned $4.13 million during the quarter, compared to the consensus estimate of $8.75 million. Metagenomi had a negative net margin of 172.21% and a negative trailing twelve-month return on equity of 31.21%.

Metagenomi (MGX) raised $94 million in an initial public offering (IPO) on Friday, February 9th 2024. The company issued 6,250,000 shares at $15.00 per share.

Metagenomi's top institutional investors include Peapod Lane Capital LLC (1.36%), Geode Capital Management LLC (0.79%), Good Life Advisors LLC (0.54%) and Vanguard Personalized Indexing Management LLC (0.06%). Insiders that own company stock include Brian C Thomas, Holdings A/S Novo, Sarah B Noonberg and Pamela Wapnick.
View institutional ownership trends
.

Shares of MGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Metagenomi investors own include Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Home Depot (HD).

Company Calendar

Last Earnings
5/13/2025
Today
8/08/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MGX
Previous Symbol
NASDAQ:MGX
CIK
1785279
Fax
N/A
Employees
236
Year Founded
N/A

Price Target and Rating

High Price Target
$17.00
Low Price Target
$7.00
Potential Upside/Downside
+577.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$78.06 million
Net Margins
-172.21%
Pretax Margin
-184.18%
Return on Equity
-31.21%
Return on Assets
-22.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.85
Quick Ratio
5.85

Sales & Book Value

Annual Sales
$52.29 million
Price / Sales
1.37
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.28 per share
Price / Book
0.31

Miscellaneous

Outstanding Shares
37,380,000
Free Float
30,727,000
Market Cap
$71.77 million
Optionable
N/A
Beta
-0.12

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:MGX) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners